未破裂脑动脉瘤手术与介入治疗患者的综合神经心理评估:前瞻性观察研究
该前瞻性观察研究纳入109例未破裂脑动脉瘤患者,65例行显微手术、44例行血管内治疗,采用MoCA、HADS和SF-36在治疗前及治疗后多个时间点评估认知、焦虑抑郁与生活质量。结果显示两种治疗在两年内均未导致整体认知功能下降,焦虑抑郁症状趋于改善,生活质量稳定。
要点
- 显微手术与血管内治疗在两年随访内均未引起整体认知功能下降。
- 治疗前存在认知 impairment 者部分在6个月和12个月恢复。
- 术后短暂并发症未影响长期认知结局,治疗前神经心理评估有助个体化规划。
核心结论
- 显微手术与血管内治疗未破裂脑动脉瘤在两年随访内均未导致整体认知功能下降。
- 焦虑和抑郁症状在治疗后趋于改善,生活质量评分保持稳定。
- 术后短暂并发症未影响长期认知结局,识别患者和动脉瘤相关危险因素对个体化规划重要。
研究设计与样本
- 前瞻性观察研究纳入109例未破裂脑动脉瘤患者,65例行显微手术,44例行血管内治疗。
- 采用MoCA评估认知功能,HADS评估焦虑抑郁,SF-36评估生活质量。
- 评估时间点为治疗前、出院时及治疗后6个月、1年、2年。
主要发现
- 治疗前24例患者MoCA测试显示认知 impairment,这些患者年龄显著更大且焦虑或抑郁发生率更高。
- 6个月时2例术前认知正常患者出现新发缺陷,伴术后短暂并发症,均在12个月完全恢复。
- 基线认知 impairment 者中10例在6个月恢复,另4例在12个月恢复。
- 24个月时99例MoCA评分正常,10例存在持续术前缺陷。
关键数值与推荐
- 认知功能采用MoCA测试评估。
- 焦虑和抑郁采用医院焦虑抑郁量表(HADS)评估。
- 生活质量采用SF-36问卷评估。
临床怎么用
- 治疗前应进行神经心理评估以识别认知 impairment 及焦虑抑郁风险患者。
- 个体化规划需考虑患者和动脉瘤相关危险因素。
- 术后短暂并发症不预示长期认知不良结局。
局限性
- 本研究为前瞻性观察研究,非随机对照设计。
- 原文未报告样本量计算、失访率及统计效能等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of unruptured cerebral aneurysms has evolved through new surgical and endovascular approaches. Its goal is to ensure the patient survival with a good quality of life, so cognitive outcome should be considered a critical factor in the decision-making analysis. This study aimed to investigate the impact of unruptured cerebral aneurysm treatment on cognitive function. METHOD: This prospective study enrolled 109 patients with unruptured cerebral aneurysms, 65 treated with microsurgery and 44 with endovascular procedures. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) test, anxiety and depression using the Hospital Anxiety and Depression Scale (HADS), and quality of life by the SF-36 questionnaire. Potential risk factors influencing the neuropsychological assessment were recorded. Patients were evaluated before treatment, at discharge and at 6-months, 1-year and 2-years post treatment. RESULTS: Before treatment, 24 patients exhibited a cognitive impairment on the MoCA test. These 24 cases were significantly older and had higher incidence of anxiety or depression under treatment. At 6 months two patients with preoperatively normal cognitive function developed a new deficit: they presented transient post-surgical complications and investigated risk factors. These two patients recovered completely at 12 months. Among those with baseline impairment 10 patients recovered at 6 months and 4 more at 12 months. At 24 months, 99 patients presented with normal MoCA scores and 10 patients showed persistent preoperative deficit. CONCLUSIONS: Neither minimally invasive microsurgery nor endovascular treatment was associated with a decline in global cognitive function within two years of follow-up. Anxiety and depression symptoms tended to improve post treatment, while quality-of-life scores remained stable. Transient postoperative complications did not influence long term cognitive outcomes. These findings highlight the importance of recognizing patient and aneurysm related risk factors that may predispose to cognitive decline. Individualized planning and pre-treatment neuropsychological assessment are therefore essential.
引用
- Galeazzi M, Di Bonaventura R, Grilli FV, et al. Integrated neuropsychological assessment in patients undergoing neurosurgical and endovascular treatment of unruptured cerebral aneurysms: results of a prospective observational study. Acta Neurochir (Wien). 2026. PMID: 41735664. doi:10.1007/s00701-026-06803-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。